Abstract
The susceptibility ofMycobacterium kansasii to antibacterial agents alone and in combination was studied. Widespread resistance to ethambutol, ciprofloxacin and isoniazid was found when these drugs were tested separately. However, pronounced antibacterial effects were seen when ethambutol was tested in combination with ciprofloxacin, rifampicin or rifabutin, which corresponded to significantly decreased resistance to these drugs in combination.
Similar content being viewed by others
References
Hoffner SE, Svenson SB, Källenius G Synergistic effects of antimycobacterial drugs onMycobacterium avium complex determined radiometrically in liquid medium. European Journal of Clinical Microbiology 1987, 6: 530–535.
Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Källenius G In vitro synergistic activity between ethambutol and flourinated quinolones againstMycobacterium avium complex. Journal of Antimicrobial Chemotherapy 1989, 24: 317–324.
Kubín M, Svandová E, Medek B, Chobot S, Olsovsky Z Mycobacterium kansasii infections in an endemic area of Czechoslovakia. Tubercle 1980, 61: 107–112.
Middlebrook G, Reggiardo Z, Tigertt WD Automatable radiometric detection of growth ofMycobacterium tuberculosis in selective media. American Reviews of Respiratory Diseases 1977, 115: 1066–1069.
Heifets LB, Iseman MD Determination of in vitro susceptibility of mycobacteria to ansamycin. American Reviews of Respiratory Diseases 1985, 132: 710–711.
Good RC, Silcox VA, Kilburn JO, Plikaytis BD Identification and drug susceptibility test results forMycobacterium spp. Clinical Microbiology Newsletter 1985, 7: 133–136.
Heifets LB, Iseman MD, Lindholm-Levy PJ, Kanes W Determinations of ansamycin MICs forMycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrobial Agents and Chemotherapy 1985, 28: 565–578.
David HL Basis for lack of drug susceptibility of atypical mycobacteria. Reviews of Infectious Diseases 1981, 3: 878–884.
Rastogi N, Frehel C, Ryter A, Ohayon H, Lesourd M, David HL Multiple drug resistance inMycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? Antimicrobial Agents and Chemotherapy 1981, 20: 666–677.
Hoffner SE, Källenius G, Beezer AE, Svenson SB Studies on the mechanisms of the synergistic effects of ethambutol and other antibacterial drugs onMycobacterium avium complex. Acta Leprologica 1989, 7, Supplement 1: 195–199.
Källenius G, Svenson SB, Hoffner SE Ethambutol: a key forMycobacterium avium complex chemotherapy? American Reviews of Respiratory Diseases 1989, 140: 264.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hjelm, U., Kaustová, J., Kubín, M. et al. Susceptibility ofMycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. Eur. J. Clin. Microbiol. Infect. Dis. 11, 51–54 (1992). https://doi.org/10.1007/BF01971272
Issue Date:
DOI: https://doi.org/10.1007/BF01971272